Keywords: سندرم میلوسپلاستی (MDS); Haploidentical stem cell transplant; Post-transplant cyclophosphamide; Elderly patients; Acute myeloid leukemia (AML); Myelodysplastic syndrome (MDS);
مقالات ISI سندرم میلوسپلاستی (MDS) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سندرم میلوسپلاستی (MDS); Myelodysplastic syndrome (MDS); monosomal karyotype (MK); monosomies of chromosome 5/7; prognostic significance;
Keywords: سندرم میلوسپلاستی (MDS); Myelodysplastic syndrome (MDS); Systematic review; Clinical trials; Immunomodulatory agents; Lenalidomide; Thalidomide;
Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature
Keywords: سندرم میلوسپلاستی (MDS); Acute myelocytic leukemia (AML); Secondary clone; Myelodysplastic syndrome (MDS); Therapy-related acute myelocytic leukemia (t-AML); Therapy-related myelodysplastic syndrome (t-MDS); AML; acute myelocytic leukemia; APL; acute promyelocytic leukemia; ATO;
Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup
Keywords: سندرم میلوسپلاستی (MDS); Der(5;17); complex karyotypes; TP53; acute myeloid leukemia (AML); myelodysplastic syndrome (MDS)
Mutational profiling in patients with MDS: Ready for every-day use in the clinic?
Keywords: سندرم میلوسپلاستی (MDS); myelodysplastic syndrome (MDS); mutations; amplicon deep-sequencing; next-generation sequencing; NGS; diagnostic algorithm
An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes
Keywords: سندرم میلوسپلاستی (MDS); Aurora A kinase inhibitor; Alisertib; Safety; Acute myeloid leukemia (AML); Myelodysplastic syndrome (MDS);
Does matched unrelated donor transplantation have the same outcome as matched sibling transplantation in unselected patients?
Keywords: سندرم میلوسپلاستی (MDS); acute myeloid leukemia; allogeneic transplant; HLA-identical sibling; matched unrelated donor; myelodysplastic syndrome (MDS); pediatric
The classification of MDS: From FAB to WHO and beyond
Keywords: سندرم میلوسپلاستی (MDS); WHO classification; FAB classification; Myelodysplastic syndrome (MDS);
Efectividad y seguridad del régimen FLAG-IDA en leucemias agudas resistentes o recidivantes
Keywords: سندرم میلوسپلاستی (MDS); FLAG-IDA; Efectividad; Seguridad; Leucemias agudas; SÃndromes mielodisplásicos (SMD); FLAG-IDA; Effectiveness; Safety; Acute leukaemia; Myelodysplastic syndrome (MDS);
Pretransplantation Therapy with Azacitidine vs Induction Chemotherapy and Posttransplantation Outcome in Patients with MDS
Keywords: سندرم میلوسپلاستی (MDS); Azacitidine; Myelodysplastic syndrome (MDS); Induction chemotherapy; Hypomethylation; Reduced-intensity conditioning
Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes?
Keywords: سندرم میلوسپلاستی (MDS); azacitidine; decitabine; hypomethylating agent; myelodysplastic syndrome (MDS)
Mouse models of myelodysplastic syndromes
Keywords: سندرم میلوسپلاستی (MDS); Myelodysplastic syndrome (MDS); Mouse models; del(5q); Xenotransplantation;
Myelodysplastic syndromes
Keywords: سندرم میلوسپلاستی (MDS); Myelodysplastic syndrome (MDS); Pathogenesis; Refractory cytopenia with unilineage dysplasia; Refractory cytopenia with multilineage dysplasia; Refractory anemia with excess blasts; 5q- syndrome, MDS, unclassifiable;
The lower risk MDS patient at risk of rapid progression
Keywords: سندرم میلوسپلاستی (MDS); Myelodysplastic syndrome (MDS)
FISH analysis in addition to G-band karyotyping: Utility in evaluation of myelodysplastic syndromes?
Keywords: سندرم میلوسپلاستی (MDS); Myelodysplastic syndrome (MDS); Karyotype; Giemsa banding; Fluorescence in situ hybridization (FISH);
Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: An International Working Group on MDS Cytogenetics Study
Keywords: سندرم میلوسپلاستی (MDS); Myelodysplastic syndrome (MDS); Cytogenetics; Karyotype; Chromosomal abnormality; IPSS; Prognosis
The role of stem cell transplantation in the management of Non-Hodgkin's lymphoma
Keywords: سندرم میلوسپلاستی (MDS); Non-Hodgkin's lymphoma (NHL); Stem cell transplantation; Autologous bone marrow transplantation (AMBT); Peripheral blood stem cell (PBSC) transplantation; Allogeneic transplantation; Graft versus host disease (GvHD); Myelodysplastic syndrome (MDS);